Author: Leclercq, Loïc
Title: Interactions between cyclodextrins and cellular components: Towards greener medical applications? Document date: 2016_12_7
ID: 16pzlvzz_69
Snippet: Cholesterol levels in the plasma membrane are extremely important in many parts of the viral infection process such as the entry and release of virions from the host cell as well as for the transport of various viral proteins. CDs have a clear antiviral activity against influenza virus [140] , human immunodeficiency virus (HIV-1) [141] , murine corona virus [142] , poliovirus [143] , human T cell leukemia virus (HTLV-1) [144] , Newcastle virus [1.....
Document: Cholesterol levels in the plasma membrane are extremely important in many parts of the viral infection process such as the entry and release of virions from the host cell as well as for the transport of various viral proteins. CDs have a clear antiviral activity against influenza virus [140] , human immunodeficiency virus (HIV-1) [141] , murine corona virus [142] , poliovirus [143] , human T cell leukemia virus (HTLV-1) [144] , Newcastle virus [145, 146] , varicella-zoster [147] , duck and human hepatitis B virus [148, 149] , bluetongue virus [150] , etc. In these cases, the ability of CDs to decrease membrane cholesterol was proposed as antiviral mechanism. Nevertheless, the biological effects of the CDs can be classified according to their role: i) to impede the viral entry in the host cell, ii) to decrease the relative infectivity of the virions, iii) to decrease the observed viral titer, and iv) to disrupt the surface transport of influenza virus hemagglutinin. Few typical examples of the CD effect on the pathogenicity of several viruses are reported.
Search related documents:
Co phrase search for related documents- Newcastle virus and viral entry: 1, 2, 3, 4, 5
- plasma membrane and release entry: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10
- plasma membrane and surface transport: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13
- plasma membrane and viral entry: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 31, 32, 33, 34, 35, 36, 37, 38, 39, 40, 41, 42, 43, 44, 45, 46, 47, 48, 49, 50, 51, 52, 53, 54, 55, 56, 57, 58, 59, 60, 61, 62, 63, 64, 65
- plasma membrane and viral protein: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 31, 32, 33, 34, 35, 36, 37, 38, 39, 40, 41, 42, 43, 44, 45, 46, 47, 48, 49, 50, 51, 52, 53, 54, 55, 56, 57, 58, 59, 60, 61, 62, 63, 64, 65, 66, 67, 68, 69, 70, 71, 72, 73, 74, 75
- plasma membrane and viral titer: 1, 2, 3, 4
- plasma membrane and virus pathogenicity: 1, 2, 3
- relative infectivity and viral entry: 1
- relative infectivity and viral protein: 1
- relative infectivity and viral titer: 1
- release entry and viral entry: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 31, 32, 33, 34, 35, 36, 37, 38, 39, 40, 41, 42, 43, 44, 45, 46, 47, 48, 49, 50, 51, 52, 53, 54, 55, 56
- release entry and viral protein: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13
- release entry and viral titer: 1, 2
- release entry and virus pathogenicity: 1
- surface transport and viral entry: 1
- surface transport and viral protein: 1, 2, 3
- viral entry and virus pathogenicity: 1, 2, 3, 4, 5, 6, 7
- viral protein and virus pathogenicity: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22
- viral titer and virus pathogenicity: 1, 2, 3
Co phrase search for related documents, hyperlinks ordered by date